We are monitoring the impact of COVID-19 on APAC HIV Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2055
Share on
Share on

Asia Pacific HIV Diagnostics Market Research Report - Segmented By Product, Type, End-User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, & Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2055
Pages: 130

APAC HIV diagnostics Market Size (2021 to 2026):

The size of the Asia Pacific HIV Diagnostics Market is valued at USD 750.72 million in 2021. It is estimated to be growing at a growth rate of 10.40% to reach 1231.19 million by 2026.

The rise in the spread rate of infectious diseases, the increase in population growth, increased awareness on early screening for diseases and its treatment will increase the market growth. Increased set-ups of diagnostic centers, medical centers, clinics, hospitals also increase the market growth. Fully developed infrastructure and healthcare, medical facilities, medical health plans, and schemes, reimbursement policies raise demand for HIV diagnostic market. Government initiatives towards creating awareness in public about safety measures, controlling the rapid spread of infections, maintaining a healthy lifestyle, early screening of diseases, and its treatment increase market size. Rapid growth in clinical examinations and diagnostic tests, easy availability of health screening facilities, affordable range health check-up plans are also increasing market size. An increase in the number of products offers also gears up to market size. Government and non-government funds, public investors are growing demand for this market. 

Besides growth factors, few market restraints held back market growth. Factors such as limited availability of test tools and kits in the market are currently seen, which negatively impacts the market. A few tests and kits are still under clinical investigation. Delayed or slow processing of such activities will hamper the market growth. Noon affordable range of drugs for treatment, hospitality charges are reported as significant patients' concerns. However, the government provides beneficial schemes under the healthcare economy; few backward people are still unable to receive these benefits due to lack of awareness on early screening and lifestyle. The low literacy rate is more in this region, and hence due to this, there is more unawareness of disease and diagnosis. This healthy lifestyle is showing an impact on the HIV diagnostics market. The testing procedures and handling needs for professional and skilled workers. Lack of experienced staff will turn out as a negative mark for this market. The high costs of drugs and its side effects are more often a concern for patients, so patients are not readily adaptable to these systems. Testing equipment and devices need to be quality checked and monitored daily. Hence the delay in this process will mask market growth. Fewer times, the test's accuracy is not possible due to testing kit errors or reagent errors. Also, the utilization of reagents and tools are more for carrying out these procedures. 

This research report on the Asia Pacific HIV diagnostics Market has been segmented and sub-segmented into the following categories:

  • By Product: Consumables, Instruments, Software & Services                
  • By Type: Antibody Tests, Viral Identification Tests, CD4 Testing, Viral Load testing, Early Infant Diagnostics              
  • By End User: Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, Other End Users             
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC

Regional Analysis:

The Asia Pacific will see the highest market growth in coming years than earlier due to its medical and research advancements, technological developments, population growth, rise in spread rate of infectious diseases, rise in early screening for diseases and treatment, and increased medical plans and reimbursement policies. China and Japan are highly populated countries, and hence the screening tests carried out are more comparatively. China alone commands for a more spread rate of infectious diseases. In recent years, India fuelled its research activities in biotechnology, medicine, and pharmaceuticals to bring up new vaccines and a combination of drugs. However, low literacy rates and unawareness in people for healthy lifestyle activities and early screening for diseases in India will hamper the market growth.

Key companies dominating the Asia Pacific HIV Diagnostics Market profiled in this report are Abbott Healthcare, Bristol-Myers Squibb, Alere Inc., Abbvie Inc., Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, VIIV Healthcare, BD Biosciences, Beckman Coulter, Partec, Sysmex, Zyomyx Inc., Apogee Flow Systems, Mylan inc., PointCare Roche Diagnostics, Technologies Inc., Qiagen, Siemens Healthcare, and bioMerieux.

1.Introduction          

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Product

                                5.1.1 Introduction                                           

                                5.1.2 Consumables                                         

                                                5.1.2.1 Assays and Kits &Reagents                           

                                                5.1.2.2 Other Consumables                        

                                5.1.3 Instruments                                           

                                5.1.4 Software & Services                                            

                                5.1.5  Y-o-Y Growth Analysis, By Product                                              

                                5.1.6  Market Attractiveness Analysis, By Product                                            

                                5.1.7  Market Share Analysis, By Product                                              

                5.2 Type      

                                5.2.1 Introduction                                           

                                5.2.2 Antibody Tests                                      

                                                5.2.2.1 HIV Screening Tests                         

        5.2.2.1.1 Elisa    

        5.2.2.1.2 Rapid Tests      

        5.2.2.1.3 Home Access Dried Blood Spots             

                                                5.2.2.2 HIV-1 Antibody Confirmatory Tests                          

        5.2.2.2.1 Western Blot Tests       

        5.2.2.2.2  Indirect Immunofluorescence Assays (IFA)      

        5.2.2.2.3 Line Immunoassays     

        5.2.2.2.4 Radio-Immunoprecipitation Assays      

                                                5.2.2.3  HIV-2 & Group O Diagnostic Tests                            

        5.2.2.3.1 Blood Antibody Tests  

        5.2.2.3.2 DBS Tests         

        5.2.2.3.3 Line ImmunoAssay (HIV2)         

                                5.2.3 Viral Identification Tests                                    

                                                5.2.3.1 p24 Antigen Test                               

                                                5.2.3.2 Qualitative PCR Tests                      

                                                5.2.3.3 Viral Culture                        

                                5.2.4 CD4 Testing                                             

                                5.2.5 Viral Load testing                                  

                                5.2.6 Early Infant Diagnostics                                      

                                5.2.7 Y-o-Y Growth Analysis, By Type                                     

                                5.2.8 Market Attractiveness Analysis, By Type                                   

                                5.2.9 Market Share Analysis, By Type                                     

                5.3 End User      

                                5.3.1 Introduction                                           

                                5.3.2 Diagnostic Laboratories                                     

                                5.3.3 Hospitals                                  

                                5.3.4 Blood Banks                                            

                                5.3.5 Home Care Settings                                            

                                5.3.6 Other End Users                                   

                                5.3.7 Y-o-Y Growth Analysis, By End User                                             

                                5.3.8  Market Attractiveness Analysis, By End User                                          

                                5.3.9  Market Share Analysis, By End User                                            

6. Geographical Analysis                      

                6.1 Introduction       

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Product                           

                                                6.1.3.3 By Type                 

                                                6.1.3.4 By End User                        

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Product                           

                                                6.1.4.3 By Type                 

                                                6.1.4.4 By End User                        

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Product                           

                                                6.1.5.3 By Type                 

                                                6.1.5.4 By End User                        

                6.2 China     

                6.3 India      

                6.4 Japan    

                6.5 South Korea       

                6.6 Australia      

7.Strategic Analysis                

                7.1 PESTLE analysis 

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis      

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                 

                8.1 Siemens Healthineers (A Division of Siemens AG)     

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Roche Diagnostics (Division of Hoffman La Roche Ltd.)    

                8.3 Abbott Laboratories       

                8.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)  

                8.5 Thermo-Fisher Scientific Inc.       

                8.6 Merck KGaA       

                8.7 Becton, Dickinson & Company   

                8.8 Hologic Inc.

                8.9 Alere Inc.     

                8.10 Bio-Rad Laboratories    

9.Competitive Landscape                    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities                  

Appendix                   

                a) List of Tables

                b) List of Figures      

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific HIV Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  2. Asia-Pacific Consumables Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia-Pacific Instruments Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia-Pacific Software & Services Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia-Pacific HIV Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  6. Asia-Pacific Antibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia-Pacific Viral Identification tests Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia-Pacific CD4 Testing Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia-Pacific Viral Load Testing Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia-Pacific Early Infant Diagnosticss Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia-Pacific HIV Diagnostics Market, By End-User, From 2021 to 2026 (USD Million)
  12. Asia-Pacific Diagnostic Labortaries Market, By Region, From 2021 to 2026 (USD Million)
  13. Asia-Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  14. Asia-Pacific Blood Banks Market, By Region, From 2021 to 2026 (USD Million)
  15. Asia-Pacific Home Care Settings Market, By Region, From 2021 to 2026 (USD Million)
  16. Asia-Pacific Other End Users Market, By Region, From 2021 to 2026 (USD Million)
  17. Japan HIV Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  18. Japan HIV Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  19. Japan HIV Diagnostics Market, By End-User, From 2021 to 2026 (USD Million)
  20. China HIV Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  21. China HIV Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  22. China HIV Diagnostics Market, By End-User, From 2021 to 2026 (USD Million)
  23. India HIV Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  24. India HIV Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  25. India HIV Diagnostics Market, By End-User, From 2021 to 2026 (USD Million)
  26. Australia HIV Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  27. Australia HIV Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  28. Australia HIV Diagnostics Market, By End-User, From 2021 to 2026 (USD Million)
  29. South Korea HIV Diagnostics Market, By Product, From 2021 to 2026 (USD Million)
  30. South Korea HIV Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  31. South Korea HIV Diagnostics Market, By End-User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample